Skip to main content
. Author manuscript; available in PMC: 2014 Jul 1.
Published in final edited form as: Cancer Epidemiol Biomarkers Prev. 2013 Jul;22(7):1227–1238. doi: 10.1158/1055-9965.EPI-12-1432

Table 3.

Association of selected characteristics with treatment delays of >30 days in the study population

Odds Ratio (95% CI)
Characteristic Crude Model Fully Adjusted Model
Household size
1 1.00 (ref) 1.00 (ref)
2 1.89 (1.22–2.94)* 2.08(1.19–3.63)*
3 1.48 (0.85–2.58) 1.61(0.86–3.02)
4 1.18 (0.64–2.20) 1.30(0.64–2.68)
>4 0.79 (0.37–1.66) 0.87(0.38–2.01)
Lost job due to diagnosis
No 1.00 (ref) 1.00 (ref)
Yes 2.04 (0.94–4.42) 2.19(1.00–4.81)
First treatment/reconstruction
Breast conserving surgery 1.00 (ref) 1.00 (ref)
Mastectomy without reconstruction 1.30 (0.82–2.05) 1.45 (0.84–2.50)
Mastectomy with reconstruction 5.82 (3.16–10.73)* 6.18 (3.27–11.68)*
Neoadjuvant therapy 1.68 (1.05–2.71)** 2.06 (1.16–3.66)**

CI: confidence interval; Crude Model: adjusted for race, age, race x age; Fully Adjusted models: Household size additionally adjusted for marital status; Lost job due to diagnosis additionally adjusted for education; First treatment/reconstruction additionally adjusted for income, insurance, education, disease stage

*

P < 0.01

**

P < 0.05